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Introduction {#sec001}
============

It is estimated that 1.3 million patients in Australia and a further 33 million patients in the United States have diabetes \[[@pone.0167271.ref001]\]. The proportion of these thought to be undiagnosed could be in the range of 40% \[[@pone.0167271.ref001]\]. Up to 20% of surgical patients will have diabetes listed as a co-morbidity \[[@pone.0167271.ref002]\]. A recent systematic review examining survival and colorectal cancer had ranges of 3--57% of colorectal cancer patients being afflicted with diabetes \[[@pone.0167271.ref003]\]. This review concluded that patients with diabetes had higher all-cause and cancer-specific mortality, as well as poorer disease-free survival \[[@pone.0167271.ref003]\]. Research, however, is lacking in examining the effect of diabetes on perioperative morbidity and mortality in non-cardiac surgery patients. It is postulated that patients with diabetes are at higher risk of perioperative mortality and morbidity \[[@pone.0167271.ref004]\]. This higher risk is often attributed to their microvascular and macrovascular pathology. Diabetes can induce a pro-thrombotic state \[[@pone.0167271.ref002]\], which may influence perioperative outcomes. There is also speculation that hyperglycemia in itself may be an underlying factor leading to poorer outcomes \[[@pone.0167271.ref005]\]. The function of leukocytes has shown to be adversely affected under hyperglycemic conditions \[[@pone.0167271.ref006], [@pone.0167271.ref007]\], and numerous studies have shown that diabetes is a factor for increased risk in surgical wound infections \[[@pone.0167271.ref008]--[@pone.0167271.ref010]\]. This effect on poor wound healing is probably through inhibition of various mechanisms, such as inhibition of keratinocyte migration, reduced fibroblast proliferation and over-expression of c-myc \[[@pone.0167271.ref011]--[@pone.0167271.ref013]\].

Three previous studies investigated morbidity and mortality in patients with diabetes undergoing non-cardiac surgery procedures, two of which used retrospective administrative databases, and one used a national cancer registry. Yeh et al., \[[@pone.0167271.ref014]\] used a nationwide database from Taiwan comparing diabetic to non-diabetic patients and found that patients with diabetes were at higher risk of perioperative mortality, as well as at higher risk of acute renal failure and acute myocardial infarction. Fransgaard et al., \[[@pone.0167271.ref015]\] found an increased 30-day mortality for patients with diabetes but no increase in post-operative complications. Anand et al., \[[@pone.0167271.ref016]\] using the United States Nationwide Inpatient sample database, concluded that patients with diabetes had a 23% lower mortality and fewer perioperative complications compared to patients without diabetes.

These conflicting results are difficult to reconcile. It is unclear why these three studies vary so much in their results and conclusions. Anand et al., \[[@pone.0167271.ref016]\] and Fransgaard et al., \[[@pone.0167271.ref015]\] only examined patients undergoing colorectal resection, while Yeh et al., (13) examined all non-cardiac surgery patients. It may be that Anand et al., (14) had a significant number of patients that were classified as diabetic patients, but in fact had sub-clinical diabetes. We note that Yeh et al., (13) attempted to control for this by including only patients who had at least one hospital admission and one outpatient visit for diabetes in the previous 24 months. However, this may have selected out a cohort at higher risk who would have other significant co-morbidities. Fransgaard et al., \[[@pone.0167271.ref015]\] based their diagnosis of diabetes on a combination of a national patient register and a national prescription registry. No differences were found between the different diabetic medication groups (metformin, oral diabetic medication, insulin and diet control) in mortality or morbidity. Nonetheless, these three studies provide a confusing mismatch of results into the effect of diabetes on perioperative outcomes.

This study aims to investigate the perioperative morbidity and mortality outcomes of diabetic and non-diabetic colorectal cancer patients using a high quality, prospectively maintained, clinical colorectal cancer database \[[@pone.0167271.ref017]\]. It is hypothesized that patients with diabetes would have poorer perioperative outcomes, and that diabetes was an independent risk factor for both 30-day mortality and perioperative morbidity.

Materials and Methods {#sec002}
=====================

Data Source {#sec003}
-----------

The Cabrini Monash University Department of Surgery colorectal neoplasia database is a high quality, prospectively maintained research database. This database incorporates all colorectal neoplasia data from the Cabrini Hospital and The Alfred Hospital, Melbourne and all operations are performed by specialist colorectal surgeons. This database has demonstrated very high levels of data completeness, accuracy, and patient follow-up due to clinician led data entry \[[@pone.0167271.ref017]\]. It includes detailed preoperative medical profiles, and combines this with detailed perioperative surgical information as well as pathological information. Patients are followed-up for a period of 5 years post-surgery, and all data on medical or surgical complications, including recurrence, are captured. The database also contains a comprehensive set of patient data including demographics, detailed pre-morbid conditions, type and manner of surgery, cancer staging, complications and follow-up. Ethics approval for this study was granted by the Cabrini Human Research Ethics Committee (Reference \#11-22-06-15). Previous ethics approvals for this database are outlined in a published paper on the establishment on the database \[[@pone.0167271.ref017]\].

Study Population {#sec004}
----------------

An analysis of the prospectively maintained Cabrini Monash University Department of Surgery colorectal neoplasia database was conducted. The selection criterion included all patients on the database between January 2010 and April 2015 who had undergone resection of colorectal neoplasia. The length of follow-up ranged from just over five years for patients having surgery in January 2010 to three months for patients from April 2015.

Measures and Definitions {#sec005}
------------------------

Due to the clinician-led nature of the database, all entries have been verified by clinicians undertaking primary care of the patients and are verified at a fortnightly data cleansing meeting that confirms veracity of outcome measures. Basic demographic data such as age and gender were included. Co-morbid conditions that are recorded were obesity (indicated by Body Mass Index (BMI)), hypertension, ischemic heart disease, angina, chronic cardiac failure, use of an anti-platelet agent, liver disease, chronic respiratory disease, cardiovascular disease, current or ex-smoker, and chronic renal impairment or dialysis. The primary outcomes were in-hospital and outpatient 30-day mortality, and surgical or medical complications. The division of complications into surgical and medical categories was previously developed by expert opinion and was adopted by the Colorectal Surgical Society of Australia and New Zealand for their Bi-National Colorectal Cancer Audit \[[@pone.0167271.ref018]\]. Secondary outcomes included rates of return to the operating room, 30-day readmission, and length of stay.

Diabetic status was determined by the separate field allocated in the database. The data includes the diabetes type, use of oral hypoglycemics or insulin, time since diagnosis of diabetes, insulin dose, and the presence of diabetes-related complications (ischaemic heart disease, peripheral vascular disease, neuropathy). Further comparisons were made between diabetic patients with and without diabetic-related complications.

Individual patient characteristics were summarised according to diabetic status. Data on patient demographics, perioperative risks, treatment, mortality and morbidity were compiled. Primary and secondary outcomes were examined for both groups.

Statistical Analysis {#sec006}
--------------------

For patients having more than one procedure during the period of the study, the characteristic at the time of the first procedure was reported. Differences between the groups were assessed with Pearson's χ-squared tests and t-tests. Factors associated with the dichotomous outcomes of surgical complications, medical complications, return to the operating room, readmission to hospital within 30 days and 30-day mortality were investigated using separate logistic regressions for each outcome. Factors associated with length of stay were investigated using linear regression. The multivariable models for the association of diabetes with each outcome were adjusted for variables showing an independent association with the outcome. An independent association was defined a priori as a term that was significant at the 5% level in the multivariable model. A different set of adjustment variables was used for each outcome. Because some patients had more than one procedure during the period of the study, to account for the lack of independence between these observations, robust standard errors were calculated using the Huber-White Sandwich Estimator as implemented in the statistics software package Stata \[[@pone.0167271.ref019]\]. Data were analysed with Stata 13 (StataCorp LP, College Station, TX, USA).

Results {#sec007}
=======

A total of 1725 patients were analysed over 1745 treatment episodes in the study period. Twenty patients had metachronous cancers within the study period. Of the total study cohort, 267 patients had diabetes (268 surgical episodes), while 49 of these patients had one or more diabetes- related complication. [Table 1](#pone.0167271.t001){ref-type="table"} outlines the demographic and pre-morbid features of the patients, divided into patients with and without diabetes. Patients with diabetes were significantly older than patients without diabetes (median 75.7 vs. 69.6 years) and a higher proportion were male ([Table 1](#pone.0167271.t001){ref-type="table"}). A higher proportion of patients with diabetes had colon cancer and had smoked previously. Patients with diabetes were in poorer health, with statistically significant higher rates of cardiovascular disease, stroke, respiratory disease, hypertension, chronic renal failure, and peripheral vascular disease, as well as a higher mean body mass index than patients without diabetes ([Table 1](#pone.0167271.t001){ref-type="table"}).

10.1371/journal.pone.0167271.t001

###### Demographics and pre-morbid conditions.

![](pone.0167271.t001){#pone.0167271.t001g}

  Feature                                            No diabetes     \%     Diabetes       \%     P-value
  -------------------------------------------------- --------------- ------ -------------- ------ ---------
  Patients                                           1458                   267                   
  Treatment episodes                                 1477                   268                   
  Gender                                                                                          \<0.001
   - Male                                            697             47.8   174            65.2   
   - Female                                          761             52.2   93             34.8   
  Median age                                         69.6                   75.7                  \<0.001
  \- (range)                                         (18.4--100.4)          (34.1--92.5)          
  Colon cancer                                       999             68.5   202            75.7   0.02
  Rectal cancer                                      459             31.5   65             24.3   0.02
  Neoadjuvant treatment                              219             15.0   29             10.9   NS
  Median BMI[^a^](#t001fn001){ref-type="table-fn"}   25.3                   27.7                  \<0.001
   - (range)                                         (14.1--66.6)           (18.9--55.2)          
   - \< 20                                           119             8.2    4              1.5    
   - 20--24.9                                        515             35.3   65             24.3   
   - 25--29.9                                        467             32.0   74             27.7   
   - 30--39.9                                        215             14.7   76             28.5   
   - \>= 40                                          16              1.1    8              3.0    
   - not available                                   145             9.9    41             15.4   
  PVD[^b^](#t001fn002){ref-type="table-fn"}          55              3.8    37             13.9   \<0.001
  Stroke                                             93              6.4    26             9.7    0.046
  Ex-smoker                                          662             45.4   148            55.4   0.003
  Current smoker                                     101             6.9    17             6.4    NS
  Hypertension                                       606             41.6   192            71.9   \<0.001
  Chronic renal failure                              39              2.7    31             11.6   \<0.001
  Respiratory disease                                190             13.0   53             19.9   0.03
  AMI[^c^](#t001fn003){ref-type="table-fn"}          69              4.7    26             9.7    0.001
  Angina                                             28              1.9    13             4.9    0.004
  Congestive cardiac failure                         31              2.1    23             8.6    \<0.001
  Arrhythmia                                         136             9.3    51             19.1   \<0.001

^a^BMI = Body Mass Index,

^b^PVD = Peripheral vascular disease,

^c^AMI = Acute myocardial infarction;

NS = Not statistically significant

[Table 2](#pone.0167271.t002){ref-type="table"} stratifies study patients with diabetes according to the type of diabetes, duration of diabetes, presence of complications and treatment. The vast majority of patients (262, 98.1%) had type 2 diabetes, with 46 (17.2%) requiring insulin as part of their treatment. Forty-nine (18.4%) of the patients had at least one diabetes-related complication and 69.7% were receiving oral hypoglycemics.

10.1371/journal.pone.0167271.t002

###### Characteristics of diabetic patients.

![](pone.0167271.t002){#pone.0167271.t002g}

  Feature                                                               N                \%
  --------------------------------------------------------------------- ---------------- ------
  Total                                                                 267              
  Type 1 diabetes                                                       5                1.9
  Type 2 diabetes                                                       216              80.2
  Type 2 diabetes---ID[^a^](#t002fn001){ref-type="table-fn"}            46               17.2
  Mean duration, years (range)                                          10.9 (0--47)     
  Mean insulin dose, IU[^b^](#t002fn002){ref-type="table-fn"} (range)   50.9 (10--150)   
  Oral hypoglycaemic use                                                186              69.7
  Complicated diabetes                                                  49               18.4

^a^ID = Insulin dependent,

^b^IU = international unit

[Table 3](#pone.0167271.t003){ref-type="table"} describes the surgical features of the study patients. The with and without diabetes patient groups had some similarities such as rates of emergent and elective surgeries, as well similar proportions of the different surgical procedures for colon and rectal cancers. Patients with diabetes had more open procedures and a higher rate of laparoscopic to open conversions (11.2% vs. 6.9%, p = 0.02, overall Pearson's χ-squared test). Patients with diabetes scored significantly higher on the American Society of Anaestheologists (ASA) score (ASA 3 and 4; 64.1% vs. 32.4%, p\<0.001, Pearson's χ-squared test).

10.1371/journal.pone.0167271.t003

###### Surgical features of study patients.

![](pone.0167271.t003){#pone.0167271.t003g}

  Feature                                           No diabetes   \%     Diabetes   \%     P-value
  ------------------------------------------------- ------------- ------ ---------- ------ ---------
  Surgical urgency                                                                         NS
   - Emergency                                      58            4.0    5          1.9    
   - Urgent                                         86            5.9    20         7.5    
   - Elective                                       1333          91.4   243        91.0   
  ASA[^a^](#t003fn001){ref-type="table-fn"}                                                \<0.001
   - 1                                              343           23.5   9          3.4    
   - 2                                              659           45.2   88         33.0   
   - 3                                              419           28.7   150        56.2   
   - 4                                              54            3.7    21         7.9    
   - 5                                              2             0.1    0          0.0    
  Surgical entry                                                                           0.02
   - Open                                           460           31.6   93         34.8   
   - Laparoscopic                                   787           54.0   126        47.2   
   - Hybrid                                         94            6.4    18         6.7    
   - Laparoscopic -\> open                          100           6.9    30         11.2   
   - Robotic                                        35            2.4    1          0.4    
   - TA-TME[^b^](#t003fn002){ref-type="table-fn"}   1             0.1    0          0.0    
  Procedure type                                                                           NS
   - Right hemicolectomy                            502           34.4   105        39.3   
   - Left hemicolectomy                             72            4.9    16         6.0    
   - Total colectomy                                33            2.3    5          1.9    
   - Subtotal colectomy                             58            4.0    11         4.1    
   - Proctocolectomy                                18            1.2    2          0.7    
   - High anterior resection                        244           16.7   53         19.9   
   - Low anterior resection                         146           10.0   22         8.2    
   - Ultra low anterior resection                   269           18.4   32         12.0   
   - Abdominoperineal resection                     63            4.3    8          3.0    
   - Hartmann\'s procedure                          48            3.3    11         4.1    
   - Other                                          25            1.7    3          1.1    

^a^ASA---American Society of Anaesthesiologists score,

^b^TA-TME---Trans-anal total mesorectal excision;

NS = Not statistically significant

The pathological features of both study patient groups are described in [Table 4](#pone.0167271.t004){ref-type="table"}. There were no differences between the groups in terms of pathological diagnosis, lymphovascular invasion, and whether patients underwent radiotherapy. Patients without diabetes demonstrated a much higher rate of poorly differentiated cancers compared with patients with diabetes (20.7% vs. 5.9%, p = 0.03, Pearson's χ-squared test), and had a significantly higher rate (34.7% vs. 27.7%, p = 0.03) of patients undergoing chemotherapy. Although there was a difference in overall cancer stage between the groups, there was no underlying trend towards a higher or lower stage.

10.1371/journal.pone.0167271.t004

###### Pathological features of study patients.
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  Feature                        No diabetes   \%     Diabetes   \%     P-value
  ------------------------------ ------------- ------ ---------- ------ ---------
  Histological diagnosis                                                NS
   - Adenocarcinoma              1127          77.3   214        80.1   
   - Mucinous adenocarcinoma     142           9.7    30         11.2   
   - Signet cell carcinoma       13            0.9    4          1.5    
   - No residual                 106           7.3    8          3.0    
   - Dysplastic adenoma          84            5.8    12         4.5    
   - Other                       5             0.3    0          0.0    
  Differentiation                                                       0.03
   - Well differentiated         51            3.7    38         14.8   
   - Moderately differentiated   890           63.9   192        75.0   
   - Poorly differentiated       288           20.7   15         5.9    
   - Undifferentiated            11            0.8    1          0.4    
   - Not assessed                153           11.0   10         3.9    
  Overall stage                                                         0.003
   - Stage 0                     229           15.7   22         8.2    
   - Stage 1                     229           20.5   56         21     
   - Stage 2                     396           27.2   97         36.3   
   - Stage 3                     368           25.3   68         25.5   
   - Stage 4                     165           11.3   24         9      
  Lymphovascular invasion        453           32.5   78         30.5   NS
  Adjuvant chemotherapy          484           34.7   71         27.7   0.03
  Adjuvant radiotherapy          5             0.4    0          0.0    NS

NS, Not statistically significant

[Table 5](#pone.0167271.t005){ref-type="table"} compares the outcomes of patients with and without diabetes by univariate and multivariable logistic regression analyses. The presence of diabetes was associated with a significantly increased risk of surgical complications (Odds Ratio (OR) 1.45 CI 95% 1.05--1.99), and medical complications (OR 1.67, CI 95% 1.13--2.46), and increased length of stay (1.53 days, CI 95% 0.31--2.75) on univariate analysis. Multivariable analysis adjusted for variables independently associated with each outcome revealed that diabetes was an independent contributor to an increased risk of surgical complications, with no significant effect on medical complications, return to the operating room, 30-day mortality, or readmission within 30 days. The adjustment variables for each outcome are indicated below [Table 5](#pone.0167271.t005){ref-type="table"}.

10.1371/journal.pone.0167271.t005

###### Outcomes of study patients.
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  Feature                        No diabetes   \%     Diabetes   \%     Unadjusted OR (95% CI)   Adjusted^a^ OR (95% CI)
  ------------------------------ ------------- ------ ---------- ------ ------------------------ ----------------------------------------------------------
  Surgical complications         237           16.1   58         21.6   1.45 (1.05, 1.99)        1.44 (1.02, 2.04) [^a^](#t005fn001){ref-type="table-fn"}
  Medical complications          133           9.0    38         14.2   1.67 (1.13, 2.46)        1.10 (0.73, 1.68)[^b^](#t005fn002){ref-type="table-fn"}
  Return to the operating room   69            4.7    19         7.1    1.56 (0.92, 2.63         1.08 (0.57, 2.05)[^c^](#t005fn003){ref-type="table-fn"}
  30-day mortality               7             0.5    4          1.5    3.18 (0.93, 10.95)       2.47 (0.61, 10.1)[^d^](#t005fn004){ref-type="table-fn"}
  Readmission within 30 days     130           8.9    30         11.4   1.26 (0.77, 2.06)        1.33 (0.85, 2.08)[^e^](#t005fn005){ref-type="table-fn"}
  Inpatient death                9             0.6    6          2.2    1.13 (1.32, 10.58)       2.46 (0.83, 7.26)[^f^](#t005fn006){ref-type="table-fn"}

^a^---adjusted for sex, BMI, rectal cancer and operative urgency

^b^---adjusted for age, ischemic heart disease and ASA score

^c^---adjusted for age, surgical complications and medical complications

^d^---adjusted for ASA score and medical complications

^e^---adjusted for rectal cancer, surgical complications and medical complications

^f^---adjusted for surgical complications and medical complications

CI, confidence interval; OR, Odds Ratio.

A further analysis based on diabetic patients with and without diabetic-related complications was performed ([Table 6](#pone.0167271.t006){ref-type="table"}). The presence of diabetic-related complications was significantly associated with an increased 30-day mortality (OR 13.7, 95% CI 3.4--54.7), and an increased length of stay (linear regression coefficient 3.8 days, 95% CI 0.7--7.1). There was a trend to increased surgical and medical complications, as well as an increased rate of return to the operating room, although these results were not significant.

10.1371/journal.pone.0167271.t006

###### Outcomes of patients with diabetes with and without complications.
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  Feature                        OR (95% CI)                              P-value
  ------------------------------ ---------------------------------------- ---------
  Surgical complications         1.9 (0.9--3.6)                           0.2
  Medical complications          1.7 (1.0--3.8)                           0.06
  Return to the operating room   1.3 (0.4--4.4)                           0.6
  30-day mortality               13.7 (3.4--54.7)                         \<0.001
  Readmission in 30 days         0.7 (0.2--2.8)                           0.6
  Length of Stay, mean (days)    [^a^](#t006fn001){ref-type="table-fn"}   0.02

^a^Linear regression coefficient 3.8 (0.5--7.1). CI, confidence interval; OR, Odds Ratio.

The predictive factors influencing increased surgical complications in the study patients are shown in [Table 7](#pone.0167271.t007){ref-type="table"}. Body mass index (OR 1.04, 95% CI 1.01--1.06), emergency surgery (OR 3.04, 95% CI 1.54--5.98), rectal cancer (OR 2.14, 95% CI 1.36--3.36), and four surgical procedures (total colectomy, sub-total colectomy, abdominoperineal resection (APR) and Hartmann's procedure) were predictive factors in the patient cohort for surgical complications. The surgical and medical complications found in patients in this series are listed in [Table 8](#pone.0167271.t008){ref-type="table"}.

10.1371/journal.pone.0167271.t007

###### Predictive factors of surgical complications.
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  Predictor variable                                            OR     95% CI       P-value
  ------------------------------------------------------------- ------ ------------ ---------
  Diabetes                                                      1.49   1.05--2.12   0.026
  Body Mass Index                                               1.04   1.01--1.06   0.004
  Urgency                                                                           
   - Elective (Reference Group)                                 1                   
   - Urgent                                                     NS     NS           NS
   - Emergency                                                  3.04   1.54--5.98   0.001
  Rectal cancer                                                 2.14   1.36--3.36   0.001
  Surgical Procedure                                                                
   - Right or extended hemicolectomy (Reference Group)          1                   
   - Total and sub-total colectomy                              2.32   1.34--4.02   0.003
   - APR[^a^](#t007fn001){ref-type="table-fn"} and Hartmann's   1.87   1.05--3.32   0.035

^a^APR; abdominoperineal resection. CI, confidence interval; NS, Not statistically significant; OR, Odds Ratio.

10.1371/journal.pone.0167271.t008

###### List of Surgical and Medical Complications.
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  Surgical Complications         Medical Complications
  ------------------------------ ----------------------------------------------
  Abdominal/pelvic collection    DVT/PE[^a^](#t008fn001){ref-type="table-fn"}
  Anastamotic leak               Chest infection
  Enterocutaneous fistula        Cardiac
  Superficial wound dehiscence   Other
  Deep wound dehiscence          
  Wound infection                
  Sepsis                         
  Prolonged ileus                
  Small bowel obstruction        
  Urinary retention              
  Ureteric injury                
  Postoperative haemorrhage      
  Other                          

^a^DVT/PE, deep vein thrombosis/pulmonary embolism.

Discussion {#sec008}
==========

Our results indicate that although the outcome of patients with diabetes was worse than patients without diabetes, this was not significant after adjusting for other factors except in the area of surgical complications. Patients with diabetes had significantly higher co-morbidities than patients without diabetes. Therefore, it is likely that the myriad of co-morbidities that patients with diabetes have contributed more appreciably to their perioperative risk rather than the diabetes itself. This may help explain the conflicting findings of previous studies by Yeh et al., Anand et al., and Fransgaard et al., \[[@pone.0167271.ref014]--[@pone.0167271.ref016]\]. Although these previous studies have used logistic regression to try and control for confounding variables, there may be an unseen variable that is not apparent in the administrative databases used. Certainly, none of these studies control for impact and type of surgery. The finding in this study in relation to patients with diabetes and surgical complications is likely to relate to the higher rates of infection and poorer healing seen in patients with diabetes \[[@pone.0167271.ref008]\].

This study contrasts with the study by Anand et al., \[[@pone.0167271.ref016]\] that found that patients with diabetes have a 23% lower risk of mortality and lower morbidity following colorectal resection. In addition this study does not corroborate with Yeh et al., \[[@pone.0167271.ref014]\], which found that diabetes independently increases the perioperative risks to patients. To further conflict with these results, Fransgaard et al., \[[@pone.0167271.ref015]\] found no increased perioperative morbidity, but an increase of 17% in 30-day mortality in patients with diabetes. By including more variables into our multivariate analysis, we have been thorough in removing possible confounding factors in addition to ensuring that all surgeries were conducted with a specialist colorectal surgeon.

This study and previous studies, have adjusted for age, gender, and premorbid conditions. Additionally, our study adjusted for stage of disease and type of surgical procedure, absent from previous studies. Furthermore, the use of a high quality clinical database in this study minimises the possibility of a systematic error that may be present when using coding databases \[[@pone.0167271.ref014], [@pone.0167271.ref016]\].

Patients with 'minor or borderline diabetes' had been excluded in the study by Yeh et al., \[[@pone.0167271.ref014]\]. This has not been strictly defined on biochemical or clinical grounds, but rather on whether patients have had inpatient admissions or outpatient visits \[[@pone.0167271.ref014], [@pone.0167271.ref020], [@pone.0167271.ref021]\]. This non-standard definition also increases the risk that the results attributed to diabetes may be caused by an unseen factor, due to the diabetic patients who required recent admission often being frailer overall. Yeh at al., \[[@pone.0167271.ref016]\] attempted to mitigate for this using a matched system, although this does reduce the protective factor of randomization.

The quality of and access to preoperative and postoperative physician input to care may have been a factor in determining postoperative outcomes. This factor has been mitigated in our study as all patients received preoperative medical assessment and workup at either a private and or a public hospital. In addition, patients had postoperative medical assessment during their stay in hospital.

There are however some limitations to this study. Firstly, the numbers involved do not match some of the administrative-coding based studies previously published and therefore may underestimate any clinical effect of diabetes. However, the use of a high quality, clinically orientated prospective database in this study is invaluable and would be more accurate due to the involvement of clinicians in the data compilation. Secondly, the diagnosis of diabetic complications and severity are based on clinical data, rather than laboratory data such as HbA1c or fasting glucose levels. Thirdly, the data are derived from two tertiary level hospitals, and the results should be viewed from that perspective. Fourthly, the number of patients with Type 1 diabetes in this series is very low, even though a significant number of patients were classified as insulin-requiring Type 2 diabetes patients.

In this study diabetes is a marker for an increased risk of postoperative morbidity and increased length of stay, however it only remained an independent contributor to the risk of surgical complications. One of the difficulties inherent to the study of diabetic patient outcomes is that many of the premorbid conditions such as chronic renal failure and ischaemic heart disease are directly influenced by diabetes, and indeed are a marker of severity and duration of diabetes. These same conditions have adverse effects on perioperative outcomes, which can be independent of the presence of diabetes. This was reflected in our study with ischaemic heart disease being an independent predictor of medical complications. Although patients with complications of diabetes did more poorly on one measure (increased 30-day mortality), the other areas such as surgical and medical complications were not significant. This is most likely due to the fact that different complications such as ischaemic heart disease and neuropathy have different effects on the surgical outcome, as well as the smaller numbers in this cohort. Therefore, this study points out that the long-term control of diabetes to reduce the incidence and severity of these associated pre-morbid conditions is probably more important than the short-term control of perioperative hyper- and hypo- glycaemia. Although outcomes such as wound infection have had direct association with hyper- and hypo- glycaemia \[[@pone.0167271.ref008]--[@pone.0167271.ref010]\], this area is not well studied. This adds another argument to effective long-term control of diabetes; that is, the improvement of perioperative outcomes. Clinicians and patients should realise that a short-term improvement in diabetic control peri-operatively is unlikely to reduce perioperative risk. Further research targeting the perioperative effects of hypoglycaemia and hyperglycaemia is required.
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